• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Synthes

Anonymous board for Synthes
Replies
6
Views
577
Replies
12
Views
3K
anonymous
Replies
8
Views
2K
anonymous
Replies
14
Views
6K
anonymous
Replies
21
Views
5K
anonymous
Replies
15
Views
9K
anonymous
Replies
7
Views
3K
anonymous
Replies
5
Views
3K
anonymous
Replies
1
Views
2K
anonymous
Replies
1
Views
3K
anonymous
Replies
11
Views
6K
anonymous
Replies
6
Views
5K
anonymous
Replies
14
Views
8K
anonymous
Replies
20
Views
14K
anonymous
Replies
13
Views
11K
anonymous
Replies
47
Views
18K
anonymous
Replies
4
Views
4K
KennyL
Replies
2
Views
3K
anonymous